ISO TS 10974-2018 评估有植入式医疗设备的患者进行磁共振成像的安全性
VIP免费
TECHNICAL
SPECIFICATION
ISO/TS
10974
Second edition
2018-04
Assessment of the safety of magnetic
resonance imaging for patients with
an active implantable medical device
Evaluation de la sécurité de I'imagerie par résonance magnétique
pour les patients avec un dispositif médical implantable actif
Reference number
ISO/TS 10974:2018(E)
C ISO 2018
ISO/TS 10974:2018(E)
COPYRIGHT PROTECTED DOCUMENT
C ISO 2018
All rights reserved.Unless otherwise specified,or required in the context of its implementation,no part of this publication may
be reproduced or utilized otherwise in any form or by any means,electronic or mechanical,including photocopying,or posting
on the internet or an intranet,without prior written permission.Permission can be requested from either ISO at the address
below or ISO's member body in the country of the requester.
ISO copyright office
CP 401·Ch.de Blandonnet 8
CH-1214 Vernier,Geneva
Phone:+41227490111
Fax:+41227490947
Email:copyright@iso.org
Website:www.iso.org
Published in Switzerland
ii CISO 2018-All rights reserved
ISO/TS 10974:2018(E)
Contents Page
Foreword ........................................................................................................................................................................... vii
Introduction ................................................................................................................................................................. ii
1 Scope ..........................................................................................................................................................................
1
2 Normative references ......................................................................................................................................1
3 Terms and definitions ....................................................................................................................................... 1
4 Symbols and abbreviated terms ................................................................................................................... 6
5 General requirements for non -implantable parts..................................................................................6
6 Requirements for particular AIMDs ........................................................................................................... 6
7 General considerations for application of the tests of this documen .............................................. 6
7.1 Compliance criteria ................................................................................................................................. 6
7.2 Use of tiers ...............................................................................................................................................7
7.3 Test repors ...............................................................................................................................................7
7.3.1 Genera .......................................................................................................................................7
7.3.2 Description of the AIMD under tes ................................................................................... 7
7.3.3 Test methods and results ..................................................................................................... 7
8Protection from harm to the patient caused by RF-induced hea in ............................................... 8
8.1 Introduction ...............................................................................................................................................8
8.2 Outline of the Stage 1 four -tier approach ....................................................................................... 8
8.3 Measurement system prerequisites forall tiers ...........................................................................10
8.3.1 RF field source ......................................................................................................................10
8.3.2 Tissue simulating phantom .................................................................................................10
8.3.3 Definition of power deposition ...........................................................................................12
8.3.4 Measurement system validation ......................................................................................12
8.4 Determination of RF-induced power deposition in a tissue simulating medium ............... 12
8.4.1 General ................................................................................................................................... 12
8.4.2 Determine location of hot spots around the AIMD....................................................... 13
8.4.3 Determination of spatial (3D) distribution of power deposition for each
hot spo.......................................................................................................................................13
8.4.4 Determine the final power deposition ........................................................................... 14
8.5 Proximity effect of electrodes from multiple leads ..................................................................... 16
8.6 Modelling prerequisites for Tier 2, Tier 3, and Tier4 ............................................................... 17
8.7 Tier selection for RF-induced power deposition ........................................................................... 17
8.7.1 Genera .....................................................................................................................................17
8.7.2 Tier 1....................................................................................................................................... 17
8.7.3 Tier ..........................................................................................................................................18
8.7.4 Tier 3....................................................................................................................................... 19
8.7.5 Tier 4 .......................................................................................................................................20
8.8 In vitro model validation......................................................................................................................21
8.9 Overall uncertainty analysis ............................................................................................................... 23
8.10 In vivo analysis of power deposition ............................................................................................... 24
8.11 RF-induced heating assessment flow char......................................................................................24
9 Protection from harm to the patient caused by gradient -induced device heating ............... 27
9.1 Introduction ........................................................................................................................................... 27
9.2 Testing considerations ....................................................................................................................... 28
9.2.1 Genera ................................................................................................................................... 28
9.2.2 Determination of |dB/ dt | rms exposure limits .............................................................29
9.2.3 Determination of test duration ...........................................................................................29
9.3 Test requirements ................................................................................................................................. 29
9.3.1 General ................................................................................................................................... 29
9.3.2 In vitro test phantom or other suitable container ...................................................... 30
9.3.3 Gelled solution ....................................................................................................................... 30
◎ISO 2018-All rights reserved iii
摘要:
展开>>
收起<<
TECHNICALSPECIFICATIONISO/TS10974Secondedition2018-04AssessmentofthesafetyofmagneticresonanceimagingforpatientswithanactiveimplantablemedicaldeviceEvaluationdelasécuritédeI'imagerieparrésonancemagnétiquepourlespatientsavecundispositifmédicalimplantableactifReferencenumberISO/TS10974:2018(E)CISO2018I...
声明:如果您的权利被侵害,请联系我们的进行举报。
相关推荐
-
GB∕T 25915.2-2021 洁净室及相关受控环境 第2部分:洁净室空气粒子浓度的监测
2024-04-17 999+ -
GB∕T 25915.3-2024洁净室及相关受控环境 第3部分:检测方法VIP免费
2024-08-09 127 -
(高清)GB∕T 25915.3-2024 洁净室及相关受控环境第3部分:检测方法VIP免费
2025-08-27 999+ -
GB∕T 16886.1-2025医疗器械生物学评价 第1部分 风险管理过程中生物学安全性评价的要求和通用原则(草案稿)VIP免费
2025-09-02 834 -
GB∕T 16886.11-2021 医疗器械生物学评价 第11部分:全身毒性试验VIP免费
2025-09-02 866 -
GB∕T 191-2025 包装储运图示标志(征求意见稿)VIP免费
2025-09-29 999+ -
GB∕T 19000-2016 质量管理体系 基础和术语(高清)VIP免费
2025-10-27 999+ -
GB∕T 19001-2016 质量管理体系要求
2025-10-27 999+ -
GB∕T 16292-2025 医药工业洁净室(区)悬浮粒子的测试方法VIP免费
2025-10-29 999+ -
GB∕T 16292《医药工业洁净室(区)悬浮粒子的测试方法》2010版和2025版对比分析(逐条对比)VIP免费
2025-10-30 579
作者:多多猪
分类:法规规范
价格:80质量币
属性:228 页
大小:5.2MB
格式:PDF
时间:2025-10-30

